A minority of group 3/4 medulloblastoma tumours harbour single-gene oncogenic drivers, including MYC10 and MYCN11 amplifications as well as PRDM6 overexpression owing to enhancer hijacking by means of a tandem duplication of the adjacent SNCAIP gene2. This evidence concerns the gene SNCAIP and medulloblastoma.